Teva is paying $20 million in cash and will contribute $25 million worth of Suboxone, an opioid addiction treatment.
Source: Jerusalem Post
Full Article: Averting opioid trial, Teva, drug distributors reach last-gasp settlement
Teva is paying $20 million in cash and will contribute $25 million worth of Suboxone, an opioid addiction treatment.
Source: Jerusalem Post
Full Article: Averting opioid trial, Teva, drug distributors reach last-gasp settlement